Cumberland Pharmaceuticals (CPIX) Tops Q1 EPS by 3c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Gordon Haskett cuts TJX Companies rating to Accumulate
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Dingdong (DDL) Reports Q2 EPS of RMB0.90